Title: Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.
Journal: Journal of medicinal chemistry 20061116
138505-25-6
20037-38-1
6280-80-4
79636-94-5
24581-99-5
171347-47-0
24652-66-2 | 2-Fluorobenzaldoxime | AA002OVZ | MFCD00019958
2473-03-2 | 1-Chloroundecane | AA002P6X | MFCD00040870
248274-03-5 | 2-Aminomethylphenylboronic acid | AA002PIM | MFCD06212997
2492-23-1 | (2,4-Dichlorobenzyl)triphenylphosphonium chloride | AA002PSH | MFCD00031641
25016-09-5 | 1,3-Dimethyl-1h-pyrazole-5-carbaldehyde | AA002Q4U | MFCD02681907
25125-21-7 | 1-Hydroxymethyl-3-cyclopentene | AA002QGX | MFCD04038630
251912-68-2 | 3-(3-Methoxy-phenyl)-isoxazole-5-carbaldehyde | AA002QQW | MFCD06738506
259270-28-5 | Phosphonofluoridic acid, P-[10-[[5-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]pentyl]amino]-10-oxodecyl]-, ethyl ester | AA002R0W | MFCD02094222
26028-88-6 | 4-(5-Mercapto-4-phenyl-4H-1,2,4-triazol-3-yl)phenol | AA002RCF | MFCD00955238
261165-02-0 | Boc-l-2-bromophenylalanine | AA002RNJ | MFCD01317709